HomeAPPH • ETR
add
Apontis Pharma AG
Previous close
€10.20
Day range
€10.05 - €10.35
Year range
€4.12 - €10.55
Market cap
88.81M EUR
Avg Volume
8.53K
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 11.36M | 19.25% |
Operating expense | 6.44M | -24.52% |
Net income | 351.40K | 119.96% |
Net profit margin | 3.09 | 116.72% |
Earnings per share | — | — |
EBITDA | 1.07M | 153.33% |
Effective tax rate | 19.11% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 16.16M | -38.58% |
Total assets | 48.20M | -9.81% |
Total liabilities | 17.24M | 11.93% |
Total equity | 30.97M | — |
Shares outstanding | 8.33M | — |
Price to book | 2.74 | — |
Return on assets | 2.54% | — |
Return on capital | 3.95% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 351.40K | 119.96% |
Cash from operations | -1.94M | 56.81% |
Cash from investing | -327.62K | 38.41% |
Cash from financing | -3.06M | -43,766,485.71% |
Net change in cash | -5.33M | -6.16% |
Free cash flow | 528.84K | 130.72% |
About
Founded
1946
Website
Employees
177
